Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| STaR1 | STaR1_B | U.S. | 2011 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | None | 24 |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| L90M | I13V, L19I, K20T, E35G, M36I, R41K, R57G, I62V, L63T, I64V, I72T, T74S, V77I |
| >STaR1_B| codons 1-99 PQITLWQRPLVTVKIGGQITEALLDTGADDTVLEGINLPGKWKPKMIGGIGGFIKVGQYD QVTVEICGHKATGSVLIGPTPVNIIGRNLMTQIGCTLNF |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| V35I, K122E, D123N, I135L, S162C, K173N, Q174K, V179I, G196E, A272P, A288T |
| >STaR1_B| codons 1-311 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALIEICTEMEKEGKISKIGPENPYNTPV FAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPL DENFRKYTAFTIPSLNNETPGIRYQYNVLPQGWKGSPAIFQCSMTKILEPFRNKNPDIII YQYMDDLYVGSDLEIEQHRTKIEELRQHLLRWGFTTPDKKHQKEPPFLWMGYELHPDKWT VQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVKQLCKLLRGTKTLTEVIPLTEEAE LELAENREILK |
References
| Author | Title | Citation |
| Porter, DP | Characterization of HIV-1 drug resistance development through week 48 in antiretroviral naive subjects on rilpivirine/emtricitabine/tenofovir DF or efavirenz/emtricitabine/tenofovir DF in the STaR study (GS-US-264-0110) | JAIDS, 2014 |